Product
BR1015
2 clinical trials
1 indication
Indication
HypertensionClinical trial
An Open-label, Randomized, Fed, Single-dose, 2-sequence, 2-period, Crossover Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" in Healthy VolunteersStatus: Completed, Estimated PCD: 2023-10-03
Clinical trial
An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 4-period, Crossover Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" in Healthy VolunteersStatus: Completed, Estimated PCD: 2023-10-06